Darren Keith Johnson, ACNPC-AG - Medicare Nurse Practitioner in Bullhead City, AZ

Darren Keith Johnson, ACNPC-AG is a medicare enrolled "Emergency Medicine - Emergency Medical Services" physician in Bullhead City, Arizona. He graduated from medical school in 2017 and has 7 years of diverse experience with area of expertise as Nurse Practitioner. He is a member of the group practice Arizona Emergency Medicine Specialists Pc, Desert Palms Medical Associates Inc and his current practice location is 3015 Highway 95 Ste 106, Bullhead City, Arizona. You can reach out to his office (for appointments etc.) via phone at (928) 201-0881.

Darren Keith Johnson is licensed to practice in Arizona (license number AP11331) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1205328382.

Contact Information

Darren Keith Johnson, ACNPC-AG
3015 Highway 95 Ste 106,
Bullhead City, AZ 86442-4334
(928) 201-0881
(928) 763-2230



Physician's Profile

Full NameDarren Keith Johnson
GenderMale
SpecialityNurse Practitioner
Experience7 Years
Location3015 Highway 95 Ste 106, Bullhead City, Arizona
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Darren Keith Johnson graduated from medical school in 2017
  NPI Data:
  • NPI Number: 1205328382
  • Provider Enumeration Date: 06/04/2018
  • Last Update Date: 06/30/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 2062768948
  • Enrollment ID: I20180706002012

Medical Identifiers

Medical identifiers for Darren Keith Johnson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205328382NPI-NPPES
400262MedicaidAZ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207PE0004XEmergency Medicine - Emergency Medical Services AP11331 (Arizona)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Western Arizona Regional Medical CenterBullhead city, AZHospital
Havasu Regional Medical CenterLake havasu city, AZHospital
Valley View Medical CenterFort mohave, AZHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Arizona Emergency Medicine Specialists Pc892129568413
Desert Palms Medical Associates Inc88200731334

News Archive

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Brain research in desperate need of cutting-edge statistics, says Carnegie Mellon University's Rob Kass

Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.

Opinion piece calls for enhanced U.S.-Russia health collaboration

While legislators in Moscow attempt to reform the Russian health system in a way that is "strikingly similar" to the reform process in the U.S. and "[g]iven the importance of the U.S.-Russia relationship ... our two countries have a historic opportunity to expand our health collaboration and, in so doing, improve our diplomatic ties," former U.S. Senate Majority Leader Bill Frist.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Darren Keith Johnson allows following entities to bill medicare on his behalf.
Entity NameDesert Palms Medical Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467509372
PECOS PAC ID: 8820073133
Enrollment ID: O20040621001904

News Archive

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Brain research in desperate need of cutting-edge statistics, says Carnegie Mellon University's Rob Kass

Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.

Opinion piece calls for enhanced U.S.-Russia health collaboration

While legislators in Moscow attempt to reform the Russian health system in a way that is "strikingly similar" to the reform process in the U.S. and "[g]iven the importance of the U.S.-Russia relationship ... our two countries have a historic opportunity to expand our health collaboration and, in so doing, improve our diplomatic ties," former U.S. Senate Majority Leader Bill Frist.

Read more Medical News

› Verified 7 days ago

Entity NameNorthern Arizona Medical Group Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770743965
PECOS PAC ID: 6204901465
Enrollment ID: O20080826000781

News Archive

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Brain research in desperate need of cutting-edge statistics, says Carnegie Mellon University's Rob Kass

Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.

Opinion piece calls for enhanced U.S.-Russia health collaboration

While legislators in Moscow attempt to reform the Russian health system in a way that is "strikingly similar" to the reform process in the U.S. and "[g]iven the importance of the U.S.-Russia relationship ... our two countries have a historic opportunity to expand our health collaboration and, in so doing, improve our diplomatic ties," former U.S. Senate Majority Leader Bill Frist.

Read more Medical News

› Verified 7 days ago

Entity NameArizona Emergency Medicine Specialists Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134439706
PECOS PAC ID: 8921295684
Enrollment ID: O20110208000837

News Archive

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Brain research in desperate need of cutting-edge statistics, says Carnegie Mellon University's Rob Kass

Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.

Opinion piece calls for enhanced U.S.-Russia health collaboration

While legislators in Moscow attempt to reform the Russian health system in a way that is "strikingly similar" to the reform process in the U.S. and "[g]iven the importance of the U.S.-Russia relationship ... our two countries have a historic opportunity to expand our health collaboration and, in so doing, improve our diplomatic ties," former U.S. Senate Majority Leader Bill Frist.

Read more Medical News

› Verified 7 days ago

Entity NameNes Arizona Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205217700
PECOS PAC ID: 2163737206
Enrollment ID: O20150818005113

News Archive

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Brain research in desperate need of cutting-edge statistics, says Carnegie Mellon University's Rob Kass

Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.

Opinion piece calls for enhanced U.S.-Russia health collaboration

While legislators in Moscow attempt to reform the Russian health system in a way that is "strikingly similar" to the reform process in the U.S. and "[g]iven the importance of the U.S.-Russia relationship ... our two countries have a historic opportunity to expand our health collaboration and, in so doing, improve our diplomatic ties," former U.S. Senate Majority Leader Bill Frist.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Darren Keith Johnson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Darren Keith Johnson, ACNPC-AG
601 El Dorado St,
Kingman, AZ 86401-6224

Ph: (928) 897-7468
Darren Keith Johnson, ACNPC-AG
3015 Highway 95 Ste 106,
Bullhead City, AZ 86442-4334

Ph: (928) 201-0881

News Archive

New screening method could catch organ rejection much earlier without a biopsy needle

Too often, it's only after a transplanted organ has sustained serious damage that a biopsy reveals the organ is in rejection. A new screening method using sensor particles and a urine test could catch rejection much earlier, more comprehensively, and without a biopsy needle.

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Brain research in desperate need of cutting-edge statistics, says Carnegie Mellon University's Rob Kass

Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.

Opinion piece calls for enhanced U.S.-Russia health collaboration

While legislators in Moscow attempt to reform the Russian health system in a way that is "strikingly similar" to the reform process in the U.S. and "[g]iven the importance of the U.S.-Russia relationship ... our two countries have a historic opportunity to expand our health collaboration and, in so doing, improve our diplomatic ties," former U.S. Senate Majority Leader Bill Frist.

Read more News

› Verified 7 days ago


Emergency Medicine Doctors in Bullhead City, AZ

Dr. John K Davis, DO
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: 928-763-2273    
Abhilasha Singh Jones, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: 928-444-1451    
Dr. Andrew S Brenner, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1570 Paseo Grande, #2024, Bullhead City, AZ 86442
Phone: 217-621-9007    
Javed Malik, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3015 Highway 95, Suite 105, Bullhead City, AZ 86442
Phone: 928-763-2001    Fax: 928-763-2038

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.